CUSIP 90466Y103COMUNCYQ1 2025
35 filings · latest Nov 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vivo Capital, LLC | 11.37M | $6.54M |
| 2 | Great Point Partners LLC | 10.98M | $6.31M |
| 3 | Octagon Capital Advisors LP | 10.00M | $5.75M |
| 4 | Nantahala Capital Management, LLC | 9.39M | $5.40M |
| 5 | Logos Global Management LP | 5.08M | $2.92M |
| 6 | Walleye Capital LLC | 4.09M | $2.35M |
| 7 | Silverarc Capital Management, LLC | 2.41M | $1.39M |
| 8 | Acuta Capital Partners, LLC | 2.35M | $1.35M |
| 9 |
| 4 | May 15, 2025 | Vivo Opportunity Fund Holdings, L.P. | 13G/A | 10.0% | 60.96M | SEC |
| 5 | May 15, 2025 | Nantahala Capital Management, LLC | 13G/A | 10.0% | 12.24M | SEC |
| 6 | Feb 14, 2025 | Ra Capital Management, L.P. | 13G/A | 9.9% | 11.52M | SEC |
| 7 | Feb 14, 2025 | Great Point Partners, LLC | 13G/A | 10.0% | 11.47M | SEC |
| 8 | Feb 6, 2025 | Walleye Capital LLC | 13G/A | 4.8% | 5.00M | SEC |
| 9 | Dec 20, 2024 | Nantahala Capital Management, LLC | 13G/A | 10.0% | 10.88M | SEC |
| 10 | Dec 20, 2024 | Nantahala Capital Partners Limited Partnership | 13G/A | 2.8% | 3.01M | SEC |
See the full Schedule 13D/13G history for Unicycive Therapeutics Inc.
Unlock full history| Alyeska Investment Group, L.P. |
| 1.75M |
| $1.01M |
| 10 | Vanguard Group Inc | 1.21M | $697.2K |